Esperion Therapeutics (ESPR) – Analysts’ Recent Ratings Changes
Several brokerages have updated their recommendations and price targets on shares of Esperion Therapeutics (NASDAQ: ESPR) in the last few weeks: 12/18/2024 – Esperion Therapeutics is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $4.00 price target on the stock. 12/17/2024 – Esperion Therapeutics is now […]
More Stories
Dutch Bros (NYSE:BROS) Reaches New 52-Week High – Here’s What Happened
Dutch Bros Inc. (NYSE:BROS – Get Free Report) reached a new 52-week high during trading on Thursday . The company...
Edgewater Wireless Systems (CVE:YFI) Trading Up 15.4% – Still a Buy?
Edgewater Wireless Systems Inc. (CVE:YFI – Get Free Report)’s share price traded up 15.4% during mid-day trading on Thursday ....
Coeur Mining (NYSE:CDE) Shares Up 8.7% – Here’s Why
Coeur Mining, Inc. (NYSE:CDE – Get Free Report) shot up 8.7% on Thursday . The stock traded as high as...
Trump Staffer Credited With Garbage Truck Appearance Tapped to Be Executive Producer
By Katabella Roberts President-elect Donald Trump announced on Dec. 31 that Justin Caporale—who is credited with organizing his campaign event...
Limiting Calories Won’t Sustain Weight Loss, as Hormones Run the Show
By Sheridan Genrich “I’m eating fewer calories and exercising more, but I still can’t lose weight.” As a nutritionist, I...
Chenghe Acquisition I Co. Enters into Prepaid Share Forward Agreement
Chenghe Acquisition I Co. (NASDAQ:LATGU) recently disclosed in an 8-K filing to the Securities and Exchange Commission on January 2,...